Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Seminars in Musculoskeletal Radiology
|
January 24, 2003
Drug-induced metabolic bone disorders
Jack Lawson
Veterinary Record Open
|
August 3, 2023
Analysis of lower urinary tract signs and bacteriuria in cats with subcutaneous ureteral bypass systems
Luba Djoneva, Jack Lawson, Lynda Rutherford, et al.
Journal of Veterinary Internal Medicine
|
February 26, 2026
Chronic inflammatory enteropathy without moderate to severe hypoalbuminemia: long-term outcome in 60 dogs
Sarah Caulfield, Simon L Priestnall, Jack Lawson, et al.
Journal of the American Veterinary Medical Association
|
December 24, 2025
Association of preoperative anemia on perioperative complications and short-term outcomes in cats undergoing subcutaneous ureteral bypass
Joe Simon, Thomas Livingstone, Jack Lawson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 18, 2021
An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression
Ildiko Lingvay, Robert Bauer, James Baker-Knight, et al.
Veterinary Journal (London, England : 1997)
|
December 6, 2014
Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury
Jack Lawson, Jonathan Elliott, Caroline Wheeler-Jones, et al.
Ecology and Evolution
|
February 22, 2024
Acoustic features as a tool to visualize and explore marine soundscapes: Applications illustrated using marine mammal passive acoustic monitoring datasets
Simone Cominelli, Nicolo' Bellin, Carissa D Brown, et al.
Endocrinology, Diabetes & Metabolism
|
July 19, 2021
A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease
Lyndon Marc Evans, Linda Mellbin, Pierre Johansen, et al.
Diabetes, Obesity & Metabolism
|
October 17, 2022
Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long-term cost-effectiveness analysis based on SUSTAIN 11
Marc Evans, Barrie Chubb, Samuel J P Malkin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 26, 2022
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes
Ildiko Lingvay, Andrei-Mircea Catarig, Jack Lawson, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Seminars in Musculoskeletal Radiology
|
January 24, 2003
Drug-induced metabolic bone disorders
Jack Lawson
Veterinary Record Open
|
August 3, 2023
Analysis of lower urinary tract signs and bacteriuria in cats with subcutaneous ureteral bypass systems
Luba Djoneva, Jack Lawson, Lynda Rutherford, et al.
Journal of Veterinary Internal Medicine
|
February 26, 2026
Chronic inflammatory enteropathy without moderate to severe hypoalbuminemia: long-term outcome in 60 dogs
Sarah Caulfield, Simon L Priestnall, Jack Lawson, et al.
Journal of the American Veterinary Medical Association
|
December 24, 2025
Association of preoperative anemia on perioperative complications and short-term outcomes in cats undergoing subcutaneous ureteral bypass
Joe Simon, Thomas Livingstone, Jack Lawson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 18, 2021
An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression
Ildiko Lingvay, Robert Bauer, James Baker-Knight, et al.
Veterinary Journal (London, England : 1997)
|
December 6, 2014
Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury
Jack Lawson, Jonathan Elliott, Caroline Wheeler-Jones, et al.
Ecology and Evolution
|
February 22, 2024
Acoustic features as a tool to visualize and explore marine soundscapes: Applications illustrated using marine mammal passive acoustic monitoring datasets
Simone Cominelli, Nicolo' Bellin, Carissa D Brown, et al.
Endocrinology, Diabetes & Metabolism
|
July 19, 2021
A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease
Lyndon Marc Evans, Linda Mellbin, Pierre Johansen, et al.
Diabetes, Obesity & Metabolism
|
October 17, 2022
Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long-term cost-effectiveness analysis based on SUSTAIN 11
Marc Evans, Barrie Chubb, Samuel J P Malkin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 26, 2022
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes
Ildiko Lingvay, Andrei-Mircea Catarig, Jack Lawson, et al.
Page
of 3